Phillip H. Kuo, MD, PhD

Associate Professor, Radiology, Medicine and Biomedical Engineering

Section Chief, Nuclear Medicine

Director PET/CT

Email Address: 

Clinical Information


Research Information

Research Program: 
Cancer Imaging
Member Status: 
Research Member
Year of Membership Acceptance: 
Summary of Research Activity: 

Contrast agent development, image-directed therapy, PET/CT for monitoring of response to therapy, imaging of the immune system (immunotherapy, inflammatory diseases, and infection), PET/CT for planning of radiation therapy, PET/CT instrumentation, magnetic resonance imaging, bioenergetics.

Selected Publications: 

Bauer A and Kuo PH. Previous misdiagnosis of Parkinson disease and inappropriate treatment with placement of deep brain stimulation electrodes. ACR Case in Point. April 19, 2012.

Anavy N, Avery R, Desai C and Kuo PH. Wandering Transplant Kidney Presents as a Pitfall in Interpretation of Renal Scintigraphy for Dual Kidney Transplant. Journal of Nuclear Medicine Technology. (Accepted April 2012).

Nawas M, Kubal WS, and Kuo PH. Decreased Cerebellar Activity on FDG-PET/CT Secondary to Diffuse Idiopathic Cerebellar Calcification. Clinical Nuclear Medicine. (Accepted May 2012).

Goldberg MR and Kuo PH. Thrombus presents as palpable breast mass. The Breast Journal, 2011, 17(5), 561–563.

Kuo PH, Thompson K, Christensen I, Girardi M, and Heald PW. (Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography) FDG-PET/CT for the Evaluation of Response to Therapy of Cutaneous T-cell Lymphoma to Suberoylanilide Hydroxamic Acid in a Phase II Trial. Molecular Imaging and Biology. Nov-Dec 2008, 10(6):306-14.

Kuo PH, Chen Z, and Weidhaas J. (Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography) FDG-PET/CT for the Optimization of Planning of Radiation Therapy. Applied Radiology. Aug 2008: 1-23.

Kuo PH, McClennan BL, Thompson K, Wilson LD, Edelson RL, Heald PW, and Girardi M. (2008) FDG-PET/CT in the Evaluation of Cutaneous T-cell Lymphoma. Molecular Imaging and Biology. 10(2):74-81.

Kuo PH, Kanal E, Abu-Alfa A, and Cowper S. (2007) Gadolinium-Based MRI Contrast Agents and Nephrogenic Systemic Fibrosis. Radiology 242(3): 647-9.

Kuo PH and Shin MS. (2007) Pulmonary and Peritoneal Ossification. New England Journal of Medicine 356(17): e16.

Rye RO, Kuo PH, Holland HD. (1995) Atmospheric carbon dioxide concentrations before 2.2 billion years ago. Nature 378: 603-605.

Professional Information

Board Certifications: 

2009 - Medical Board of Arizona Licensure
2008 - American Board of Radiology
2006 - Board of Nuclear Cardiology
2004 - American Board of Nuclear Medicine
2003 - American Board of Internal Medicine
2003 - Medical Board of Connecticut Medical Licensure
4/01 - USMLE Step 3
2/00 - USMLE Step 2
6/96 - USMLE Step 1 – 99th percentile

Professional Affiliations: 

Member of the Southwest Oncology Group (SWOG)
Radiological Society of North America
Society of Nuclear Medicine
American Roentgen Ray Society
American College of Radiology
American Association for Cancer Research


Third Place for Scientific Poster at the Society of Nuclear Medicine 2012 Annual Meeting- “ROC analysis of an automated program for analyzing striatal uptake of DaTscan SPECT images: Comparison to visual reads”

American College of Radiology PET/CT Course Instructor
Reviewer for American Journal of Roentgenology
Graduate of the University of Arizona Learning to Lead Program

American Roentgen Ray Society Meeting Instructional Course Faculty
Medical Advisory Council to the Global Fibrosis Foundation

Medscape’s Top 10 Most Read Articles by Radiologists (2009)
Medscape’s #1 full-text journal article read by radiologists (2009)

Editor for issue of the Journal of the American College of Radiology entitled “Nephrogenic Systemic Fibrosis and MRI Contrast"

Academic Information

Yale New Haven Hospital, New Haven, Conn., Nuclear Medicine
Yale New Haven Hospital, New Haven, Conn., Diagnostic Radiology; UCLA Medical Center, Los Angeles, Calif., Internal Medicine
Medical School: 
University of Virginia School of Medicine, Charlottesville, Va., 2000
Master's Degree: 
University of Virginia School of Medicine, Charlottesville, Va., Molecular Physiology and Biological Physics, 1998
Undergraduate School: 
Harvard University, Cambridge, Mass., AB Chemistry, 1994